Jiangsu Nhwa Pharmaceutical Co., LTD (SHE:002262)
China · Delayed Price · Currency is CNY 19.14
-0.26 (-1.34%)
Jun 9, 2026, 3:04 PM CST
SHE:002262 Market Cap
SHE:002262 has a market cap or net worth of 19.71 billion as of June 9, 2026. Its market cap has decreased by -12.45% in one year.
Market Cap
19.71B
Enterprise Value
15.64B
Revenue
6.01B
Ranking
n/a
PE Ratio
18.29
Stock Price
19.14
Market Cap Chart
Since July 23, 2008, SHE:002262's market cap has increased from 1.26B to 19.71B, an increase of 1,458.43%. That is a compound annual growth rate of 16.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 19.71B | -19.60% |
| Dec 31, 2025 | 24.51B | -0.94% |
| Dec 31, 2024 | 24.74B | -9.45% |
| Dec 29, 2023 | 27.33B | 10.47% |
| Dec 30, 2022 | 24.74B | 56.87% |
| Dec 31, 2021 | 15.77B | -2.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tasly Pharmaceutical Group | 21.20B |
| Kangmei Pharmaceutical | 20.88B |
| Betta Pharmaceuticals | 20.57B |
| Jilin Aodong Pharmaceutical Group | 19.90B |
| Chengdu Kanghong Pharmaceutical Group | 19.65B |
| Hybio Pharmaceutical | 18.96B |
| Walvax Biotechnology | 18.92B |
| Guangdong Zhongsheng Pharmaceutical | 18.59B |